Evento

Role of RHOA-GTPASES activator, GEF-H1, in thyroid cancer

Pero, Iván ; Fernández Chávez, Lucía Icon; Carballido, Jessica Andrea Icon; Alonso, Exequiel Gonzalo Icon; Gandini, Norberto Ariel Icon; Mascaró, Marilina Icon; Pichel, Pamela ; Recio, Sergio ; Curino, Alejandro Carlos Icon; Facchinetti, Maria Marta Icon; Colo, Georgina Pamela Icon

Fecha

2020

Editorial

Fundación Revista Medicina

Revista

Título del libro

Nombre del evento

LXV Reunión Anual De La Sociedad Argentina De Investigación Clínica; LXIII Reunión Anual De La Sociedad Argentina De Inmunología y Reunión Anual De La Sociedad Argentina De Fisiología

Fecha del evento

2020-11-10

Institución organizadora

Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Inmunología
Sociedad Argentina de Fisiología

ISSN

0025-7680

eISSN

1669-9106

ISBN

Idioma

Inglés

Tipo del evento

Reunión

Clasificación temática

Resumen

GEF-H1 is a Rho-GTPases activator whose overexpression has been shown to be associated with tumor development. However, its role in thyroid cancer (TC) progression has not yet been stud- ied. TC has been dramatically rising worldwide in recent decades and represents the most prevalent endocrine malignancy. For this reason, we have begun analyzing GEF-H1 expression in human thyroid biopsies. We observed higher cytoplasmic protein concen- tration when comparing by immunohistochemistry tumor tissue (TT) with non-malignant tissue (NMT) (n=52; p=0.0003). Similar results were obtained by Western blot in thyroid biopsies and cancer cell lines. Furthermore, clinical-histopathological data showed signifi- cant GEF-H1 overexpression in TT than NMT (p=7E-07), which cor- relates with a less patient survival (p=0.0088). mRNA data analysis from biopsies (Human Protein Atlas and Oncomine platforms) also showed a significant GEF-H1 overexpression in TT compared with NMT. Analyzing Gene Expression Omnibus microarray data with R language, we observed that GEF-H1 is between 2-17% of the most expressed genes in different TC histotypes. We also determined that GEF-H1 expression is significantly higher in papillary and anaplas- tic carcinomas than NMT (p<0.05) and its expression increased in papillary carcinomas with lymph node invasion and/or metastasis (p<0.001). Moreover, we looked for those genes whose mRNA ex- pression correlates with GEF-H1 and we evaluated their function through gene ontology analysis (DAVID and STRING platforms) and their participation in signaling pathways (KEGG and Reactome). Genes associated with migration, mechanical signaling, cytoskele- ton remodeling and focal adhesions positive correlated with GEF-H1 expression in TC (p<0.001). The results suggest that GEF-H1 might be a potential tumor biomarker and/or therapeutic target in TC, since it would be involved in the pro-tumorigenic signaling by coordinating changes in cell morphology, proliferation, migration and invasion

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa